167 related articles for article (PubMed ID: 36536977)
21. Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease.
Bae JH; Lee SC
Retina; 2012 Jul; 32(7):1395-402. PubMed ID: 22012204
[TBL] [Abstract][Full Text] [Related]
22. The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma.
Frenkel S; Pe'er J; Kaufman R; Maly B; Habot-Wilner Z
Acta Ophthalmol; 2020 Sep; 98(6):e668-e673. PubMed ID: 31994839
[TBL] [Abstract][Full Text] [Related]
23. Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders.
Kurisu N; Hiyama T; Harada Y; Fukushima N; Katsuya N; Ureshino H; Ichinohe T; Kiuchi Y
Ocul Immunol Inflamm; 2022 Nov; ():1-6. PubMed ID: 36395469
[TBL] [Abstract][Full Text] [Related]
24. Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis.
Zhuang Z; Zhang Y; Zhang X; Zhang M; Zou D; Zhang L; Jia C; Zhang W
Front Oncol; 2022; 12():955080. PubMed ID: 36059608
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Accuracy of Cell Block Preparations and Clinical Features Affecting It in Vitreoretinal Lymphoma.
Kase S; Namba K; Iwata D; Mizuuchi K; Suzuki K; Ito T; Hase K; Kitaichi N; Ishida S
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268483
[TBL] [Abstract][Full Text] [Related]
26. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
27. Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches.
Takase H; Arai A; Iwasaki Y; Imai A; Nagao T; Kawagishi M; Ishida T; Mochizuki M
Prog Retin Eye Res; 2022 Sep; 90():101053. PubMed ID: 35210172
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic potential of vitreoretinal lymphoma by detection of gene mutations with NGS in 25 Chinese patients.
Chen K; Qin H; Li X; Zhou X; Ma J; Guan M
Clin Chim Acta; 2024 Jun; 561():119827. PubMed ID: 38909978
[TBL] [Abstract][Full Text] [Related]
29. B-scan ultrasound and cytology of the vitreous in primary central nervous system lymphoma with vitreoretinal involvement.
Lai J; Chen K; Shi HM; Zhuang L; Zhou X; Xiao JJ; Li Y; Chen BB; Wang QP
Int J Ophthalmol; 2019; 12(6):1001-1007. PubMed ID: 31236360
[TBL] [Abstract][Full Text] [Related]
30. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.
Cassoux N; Giron A; Bodaghi B; Tran TH; Baudet S; Davy F; Chan CC; Lehoang P; Merle-Béral H
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3253-9. PubMed ID: 17591896
[TBL] [Abstract][Full Text] [Related]
31. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies.
Schrijver B; Kolijn PM; Ten Berge JCEM; Nagtzaam NMA; van Rijswijk ALCT; Swagemakers SMA; van der Spek PJ; Missotten TOAR; van Velthoven MEJ; de Hoog J; van Hagen PM; Langerak AW; Dik WA
Acta Ophthalmol; 2022 Jun; 100(4):403-413. PubMed ID: 34318583
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
Kase S; Namba K; Iwata D; Mizuuchi K; Kitaichi N; Tagawa Y; Okada-Kanno H; Matsuno Y; Ishida S
Diagn Pathol; 2016 Mar; 11():29. PubMed ID: 26987877
[TBL] [Abstract][Full Text] [Related]
33. Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma.
Takeda A; Hasegawa E; Nakao S; Ishikawa K; Murakami Y; Hisatomi T; Arima M; Yawata N; Oda Y; Kimura K; Yoshikawa H; Sonoda KH
Sci Rep; 2020 Sep; 10(1):15715. PubMed ID: 32973297
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of intravitreal methotrexate for vitreo-retinal lymphoma - 20 years of experience.
Habot-Wilner Z; Frenkel S; Pe'er J
Br J Haematol; 2021 Jul; 194(1):92-100. PubMed ID: 33900619
[TBL] [Abstract][Full Text] [Related]
35. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
36. The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous.
Diaconita V; Rihani H; Mares V; Nehemy MB; Bakri SJ; Pulido JS
Int J Retina Vitreous; 2019; 5():19. PubMed ID: 31452937
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Accuracy of Vitreous Cytology in Patients with Vitreoretinal Lymphoma.
Lee D; Lee J; Nahm JH; Kim M
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362676
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
39. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
